Literature DB >> 6257760

Glycoprotein degradation in the blind loop syndrome: identification of glycosidases in jejunal contents.

R Prizont.   

Abstract

Contents obtained from jejunum of normal controls, self-emptying and self-filling blind loop rats were analyzed for the presence of glycoprotein-degrading glycosidases. The blind loop syndrome was documented by the increased fat excretion and slower growth rate of self-filling blind loop rats 6 wk after surgery. With p-nitrophenylglycosides as substrate, the specific activity of alpha-N-acetylgalactosaminidase, a potential blood group A destroying glycosidase, was 0.90+/-0.40 mU/mg of protein. This level was 23-fold higher than the specific activity of normal controls. In partially purified self-filling blind loop contents, the activity of alpha-N-acetylgalactosaminidase was 9- to 70-fold higher than activities of self-emptying and normal controls. Antibiotic treatment with chloromycetin and polymyxin decreased 24-fold the glycosidase levels in self-filling blind loops. In experiments with natural substrate, the blood group A titer of a20,000g supernate from normal jejunal homogenates decreased 128-fold after 24-h incubation with blind loop contents. Normal contents failed to diminish the blood group reactivity of the natural substrate. Furthermore, blind loop contents markedly decreased the blood group A titer of isolated brush borders. Incubation between blind loop bacteria and mucosal homogenates or isolated brush borders labeled with d-[U-(14)C]glucosamine revealed increased production of labeled ether extractable organic acids. Likewise, intraperitoneal injection of d-[U-(14)C]glucosamine into self-filling blind loop rats resulted in incorporation of the label into luminal short chain fatty acids. These results suggest that glycosidases may provide a mechanism by which blind loop bacteria obtain sugars from intestinal glycoproteins. The released sugars are used and converted by bacteria into energy and organic acids. This use of the host's glycoproteins would allow blind loop bacteria to grow and survive within the lumen independent of exogenous sources.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257760      PMCID: PMC370573          DOI: 10.1172/JCI110040

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Enzymes that destroy blood group specificity. I. Purification and properties of alpha-L-fucosidase from Clostridium perfringens.

Authors:  D Aminoff; K Furukawa
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

2.  Glycosidases of Phaseolus vulgaris. I. Isolation and characterization of beta-N-acetylglucosaminidase.

Authors:  O P Bahl; K M Agrawal
Journal:  J Biol Chem       Date:  1968-01-10       Impact factor: 5.157

3.  Bacterial degradation of gastrointestinal mucins. II. Bacterial origin of fecal ABH(O) blood group antigen-destroying enzymes.

Authors:  L C Hoskins
Journal:  Gastroenterology       Date:  1968-02       Impact factor: 22.682

4.  (1-14C)glucosamine incorporation by subcellular fractions of small intestinal mucosa. Identification by precursor labeling of three functionally distinct glycoprotein classes.

Authors:  G G Forstner
Journal:  J Biol Chem       Date:  1970-07-25       Impact factor: 5.157

5.  Utilization of 14C-labelled Bacillus subtilis and Escherichia coli by sheep.

Authors:  N J Hoogenraad; F J Hird; R G White; R A Leng
Journal:  Br J Nutr       Date:  1970-03       Impact factor: 3.718

6.  Importance of the isovalerate carboxylation pathway of leucine biosynthesis in the rumen.

Authors:  M J Allison; J A Bucklin; I M Robinson
Journal:  Appl Microbiol       Date:  1966-09

7.  Glycoprotein biosynthesis in small intestine. 3. Enzymatic basis for the difference in the antigenicity of mucins.

Authors:  Y S Kim; J Perdomo
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

8.  Ecological studies of intestinal bacteria. Relation between the specificity of fecal ABO blood group antigen-degrading enzymes from enteric bacteria and the ABO blood group of the human host.

Authors:  L C Hoskins
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  Bacteria, bile salts, and intestinal monosaccharide malabsorption.

Authors:  M Gracey; V Burke; A Oshin; J Barker; E F Glasgow
Journal:  Gut       Date:  1971-09       Impact factor: 23.059

10.  Rat intestinal microvillus membranes. Purification and biochemical characterization.

Authors:  G G Forstner; S M Sabesin; K J Isselbacher
Journal:  Biochem J       Date:  1968-01       Impact factor: 3.857

View more
  6 in total

1.  Human enteric population ecology and degradation of gut mucins.

Authors:  L C Hoskins
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

2.  Response of the jejunal mucosa of dogs with aerobic and anaerobic bacterial overgrowth to antibiotic therapy.

Authors:  R M Batt; L McLean; J E Riley
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Degradation of intestinal glycoproteins by pathogenic Shigella flexneri.

Authors:  R Prizont
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins.

Authors:  L C Hoskins; M Agustines; W B McKee; E T Boulding; M Kriaris; G Niedermeyer
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Intestinal microbial flora after feeding phytohemagglutinin lectins (Phaseolus vulgaris) to rats.

Authors:  J G Banwell; R Howard; D Cooper; J W Costerton
Journal:  Appl Environ Microbiol       Date:  1985-07       Impact factor: 4.792

6.  LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice.

Authors:  Honglin Tan; Mina Chen; Dejiang Pang; Xiaoqiang Xia; Chongyangzi Du; Wanchun Yang; Yiyuan Cui; Chao Huang; Wanxiang Jiang; Dandan Bi; Chunyu Li; Huifang Shang; Paul F Worley; Bo Xiao
Journal:  Cell Death Differ       Date:  2019-09-30       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.